PODD
Price
$301.05
Change
-$0.57 (-0.19%)
Updated
Jul 3 closing price
Capitalization
11.75B
33 days until earnings call
VTAK
Price
$0.23
Change
-$0.01 (-4.17%)
Updated
Jul 3 closing price
Capitalization
3.41M
Interact to see
Advertisement

PODD vs VTAK

Header iconPODD vs VTAK Comparison
Open Charts PODD vs VTAKBanner chart's image
Insulet
Price$301.05
Change-$0.57 (-0.19%)
Volume$527.29K
Capitalization11.75B
Catheter Precision
Price$0.23
Change-$0.01 (-4.17%)
Volume$737.39K
Capitalization3.41M
PODD vs VTAK Comparison Chart in %
Loading...
PODD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VTAK
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
PODD vs. VTAK commentary
Jul 06, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is PODD is a Buy and VTAK is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 06, 2025
Stock price -- (PODD: $301.62 vs. VTAK: $0.23)
Brand notoriety: PODD and VTAK are both not notable
Both companies represent the Medical Specialties industry
Current volume relative to the 65-day Moving Average: PODD: 0% vs. VTAK: 4%
Market capitalization -- PODD: $11.75B vs. VTAK: $3.41M
PODD [@Medical Specialties] is valued at $11.75B. VTAK’s [@Medical Specialties] market capitalization is $3.41M. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Medical Specialties] industry is $8.67B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

PODD’s FA Score shows that 1 FA rating(s) are green whileVTAK’s FA Score has 2 green FA rating(s).

  • PODD’s FA Score: 1 green, 4 red.
  • VTAK’s FA Score: 2 green, 3 red.
According to our system of comparison, PODD is a better buy in the long-term than VTAK.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

PODD’s TA Score shows that 3 TA indicator(s) are bullish while VTAK’s TA Score has 2 bullish TA indicator(s).

  • PODD’s TA Score: 3 bullish, 5 bearish.
  • VTAK’s TA Score: 2 bullish, 8 bearish.
According to our system of comparison, PODD is a better buy in the short-term than VTAK.

Price Growth

PODD (@Medical Specialties) experienced а -2.65% price change this week, while VTAK (@Medical Specialties) price change was -7.00% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was +1.95%. For the same industry, the average monthly price growth was +1.48%, and the average quarterly price growth was -0.02%.

Reported Earning Dates

PODD is expected to report earnings on Aug 07, 2025.

Industries' Descriptions

@Medical Specialties (+1.95% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
PODD($11.8B) has a higher market cap than VTAK($3.42M). PODD YTD gains are higher at: 15.532 vs. VTAK (-48.448).
PODDVTAKPODD / VTAK
Capitalization11.8B3.42M345,534%
EBITDA324MN/A-
Gain YTD15.532-48.448-32%
P/E Ratio57.17N/A-
Revenue1.7BN/A-
Total Cash704MN/A-
Total Debt1.42BN/A-
FUNDAMENTALS RATINGS
PODD vs VTAK: Fundamental Ratings
PODD
VTAK
OUTLOOK RATING
1..100
1398
VALUATION
overvalued / fair valued / undervalued
1..100
90
Overvalued
28
Undervalued
PROFIT vs RISK RATING
1..100
56100
SMR RATING
1..100
2699
PRICE GROWTH RATING
1..100
4765
P/E GROWTH RATING
1..100
667
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

VTAK's Valuation (28) in the Medical Specialties industry is somewhat better than the same rating for PODD (90). This means that VTAK’s stock grew somewhat faster than PODD’s over the last 12 months.

PODD's Profit vs Risk Rating (56) in the Medical Specialties industry is somewhat better than the same rating for VTAK (100). This means that PODD’s stock grew somewhat faster than VTAK’s over the last 12 months.

PODD's SMR Rating (26) in the Medical Specialties industry is significantly better than the same rating for VTAK (99). This means that PODD’s stock grew significantly faster than VTAK’s over the last 12 months.

PODD's Price Growth Rating (47) in the Medical Specialties industry is in the same range as VTAK (65). This means that PODD’s stock grew similarly to VTAK’s over the last 12 months.

VTAK's P/E Growth Rating (7) in the Medical Specialties industry is somewhat better than the same rating for PODD (66). This means that VTAK’s stock grew somewhat faster than PODD’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
PODDVTAK
RSI
ODDS (%)
Bearish Trend 3 days ago
67%
Bearish Trend 3 days ago
86%
Stochastic
ODDS (%)
Bullish Trend 3 days ago
77%
Bullish Trend 3 days ago
84%
Momentum
ODDS (%)
Bearish Trend 3 days ago
70%
Bearish Trend 3 days ago
90%
MACD
ODDS (%)
Bearish Trend 4 days ago
73%
Bearish Trend 3 days ago
90%
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
68%
Bearish Trend 3 days ago
90%
TrendMonth
ODDS (%)
Bearish Trend 3 days ago
69%
Bullish Trend 3 days ago
81%
Advances
ODDS (%)
Bullish Trend 6 days ago
71%
Bullish Trend 25 days ago
84%
Declines
ODDS (%)
Bearish Trend 18 days ago
66%
Bearish Trend 16 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
76%
Bearish Trend 3 days ago
87%
Aroon
ODDS (%)
Bullish Trend 3 days ago
73%
Bearish Trend 4 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
PODD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VTAK
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
BIBL42.010.27
+0.65%
Inspire 100 ETF
EVX38.460.23
+0.61%
VanEck Environmental Svcs ETF
SHRT7.88-0.01
-0.13%
Gotham Short Strategies ETF
SPBO29.05-0.06
-0.21%
SPDR® Portfolio Corporate Bond ETF
RFIX46.56-0.87
-1.83%
Simplify Downside Interest Rate Hedge Strategy ETF

PODD and

Correlation & Price change

A.I.dvisor indicates that over the last year, PODD has been loosely correlated with ISRG. These tickers have moved in lockstep 45% of the time. This A.I.-generated data suggests there is some statistical probability that if PODD jumps, then ISRG could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PODD
1D Price
Change %
PODD100%
N/A
ISRG - PODD
45%
Loosely correlated
+0.72%
BSX - PODD
45%
Loosely correlated
-0.44%
MMSI - PODD
39%
Loosely correlated
+0.07%
SYK - PODD
39%
Loosely correlated
+0.89%
XRAY - PODD
37%
Loosely correlated
+0.60%
More

VTAK and

Correlation & Price change

A.I.dvisor tells us that VTAK and AORT have been poorly correlated (+26% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that VTAK and AORT's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To VTAK
1D Price
Change %
VTAK100%
-4.71%
AORT - VTAK
26%
Poorly correlated
-0.42%
ITGR - VTAK
25%
Poorly correlated
-0.16%
AMBBY - VTAK
25%
Poorly correlated
N/A
KRMD - VTAK
23%
Poorly correlated
-0.55%
PODD - VTAK
22%
Poorly correlated
N/A
More